doi: 10.1001/jamainternmed.2019.0676.
Preventing Alzheimer Disease by Deprescribing Anticholinergic Medications
Affiliations
- PMID: 31233087
- DOI: 10.1001/jamainternmed.2019.0676
Item in Clipboard
Preventing Alzheimer Disease by Deprescribing Anticholinergic Medications
JAMA Intern Med.
.
No abstract available
Similar articles
-
Deprescribing to reduce polypharmacy: study protocol for a randomised controlled trial assessing deprescribing of anticholinergic and sedative drugs in a cohort of frail older people living in the community.Trials. 2021 Nov 3;22(1):766. doi: 10.1186/s13063-021-05711-w. Trials. 2021. PMID: 34732234 Free PMC article.
-
Health Care Practitioners' Perspectives on Deprescribing Anticholinergic and Sedative Medications in Older Adults.Ann Pharmacother. 2016 Aug;50(8):625-36. doi: 10.1177/1060028016652997. Epub 2016 Jun 1. Ann Pharmacother. 2016. PMID: 27257284
-
Antimuscarinic Anticholinergic Medications in Parkinson Disease: To Prescribe or Deprescribe?Mov Disord Clin Pract. 2021 Oct 8;8(8):1181-1188. doi: 10.1002/mdc3.13347. eCollection 2021 Nov. Mov Disord Clin Pract. 2021. PMID: 34765683 Free PMC article. Review.
-
Integration of an electronic Drug Burden Index risk assessment tool into Home Medicines Reviews: deprescribing anticholinergic and sedative medications.Ther Adv Drug Saf. 2019 Mar 5;10:2042098619832471. doi: 10.1177/2042098619832471. eCollection 2019. Ther Adv Drug Saf. 2019. PMID: 30858967 Free PMC article.
-
Less is More: Deprescribing Medications in Older Adults with Kidney Disease: A Review.Kidney360. 2021 Jul 9;2(9):1510-1522. doi: 10.34067/KID.0001942021. eCollection 2021 Sep 30. Kidney360. 2021. PMID: 35373095 Free PMC article. Review.
Cited by
-
Development and Pilot Testing of an Algorithm-Based Approach to Anticholinergic Deprescribing in Older Patients.Drugs Aging. 2024 Feb;41(2):153-164. doi: 10.1007/s40266-023-01089-3. Epub 2024 Feb 6. Drugs Aging. 2024. PMID: 38319492 Free PMC article.
-
Deprescribing anticholinergics in primary care older adults: Experience from two models and impact on a continuous measure of exposure.J Am Coll Clin Pharm. 2022 Oct;5(10):1039-1047. doi: 10.1002/jac5.1682. Epub 2022 Jul 31. J Am Coll Clin Pharm. 2022. PMID: 36620097 Free PMC article.
-
Anticholinergic drugs and risk of dementia: Time for action?Pharmacol Res Perspect. 2021 May;9(3):e00793. doi: 10.1002/prp2.793. Pharmacol Res Perspect. 2021. PMID: 34087056 Free PMC article.
-
Multicomponent behavioral intervention to reduce exposure to anticholinergics in primary care older adults.J Am Geriatr Soc. 2021 Jun;69(6):1490-1499. doi: 10.1111/jgs.17121. Epub 2021 Mar 26. J Am Geriatr Soc. 2021. PMID: 33772749 Free PMC article. Clinical Trial.
-
Medication transitions: Vulnerable periods of change in need of human factors and ergonomics.Appl Ergon. 2021 Jan;90:103279. doi: 10.1016/j.apergo.2020.103279. Epub 2020 Oct 10. Appl Ergon. 2021. PMID: 33049545 Free PMC article.
Grants and funding
LinkOut - more resources
Full Text Sources
